Abstract
The functions of human Apolipoproteins L (APOLs) are poorly understood, but involve diverse activities like lysis of bloodstream trypanosomes and intracellular bacteria, modulation of viral infection and induction of apoptosis, autophagy, and chronic kidney disease. Based on recent work, I propose that the basic function of APOLs is the control of membrane dynamics, at least in the Golgi and mitochondrion. Together with neuronal calcium sensor-1 (NCS1) and calneuron-1 (CALN1), APOL3 controls the activity of phosphatidylinositol-4-kinase-IIIB (PI4KB), involved in both Golgi and mitochondrion membrane fission. Whereas secreted APOL1 induces African trypanosome lysis through membrane permeabilization of the parasite mitochondrion, intracellular APOL1 conditions non-muscular myosin-2A (NM2A)-mediated transfer of PI4KB and APOL3 from the Golgi to the mitochondrion under conditions interfering with PI4KB-APOL3 interaction, such as APOL1 C-terminal variant expression or virus-induced inflammatory signalling. APOL3 controls mitophagy through complementary interactions with the membrane fission factor PI4KB and the membrane fusion factor vesicle-associated membrane protein-8 (VAMP8). In mice, the basic APOL1 and APOL3 activities could be exerted by mAPOL9 and mAPOL8, respectively. Perspectives regarding the mechanism and treatment of APOL1-related kidney disease are discussed, as well as speculations on additional APOLs functions, such as APOL6 involvement in adipocyte membrane dynamics through interaction with myosin-10 (MYH10).
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The APOL multigene family is highly dynamic, and encodes 6 human and 12 mouse protein members (phylogenetic trees in [1, 2]). However, detailed information on APOL function is only available for some members (human APOL1 and APOL3, mouse APOL6, APOL8 and APOL9) [3]. In this family, the primate-specific APOL1 is the only member containing an N-terminal signal peptide for secretion [3]. Secreted APOL1 kills the African bloodstream parasite Trypanosoma brucei brucei [4, 5]. Uptake of APOL1 triggers trypanosome lysis through lysosomal and mitochondrial membrane permeabilization due to APOL1 pore-forming activity in parasite endosomal membranes, followed by kinesin-mediated transport of the APOL1-carrying endosomes to the mitochondrion [6]. Two T. brucei subspecies termed T. b. rhodesiense and T. b. gambiense acquired resistance to APOL1, enabling these parasites to infect humans and cause sleeping sickness, in Eastern and Western Africa respectively [5]. In Western Africa, two C-terminal APOL1 variants called G1 and G2 (respectively S342G/I384M mutations and 388NY389 deletion) are widespread. Both variants exhibit in vitro killing activity on T. b. rhodesiense [7], and in the field, G2 is linked to full resistance to T. b. rhodesiense whereas G1 provides partial resistance to both T. b. rhodesiense and T. b. gambiense [8]. Thus, APOL1 initially allowed humans to survive infection by T. b. brucei, but afterwards an evolutionary arms race generated APOL1 variants to counteract acquired parasite resistance to APOL1 [5].
Besides resistance to T. b. rhodesiense infection, humans expressing the G1 or G2 variants exhibit increased susceptibility to chronic kidney disease, and this was reproduced in G1- or G2-expressing transgenic mice [7, 9, 10]. This disease results from kidney dysfunctions linked to changes of podocyte architecture and motility, accompanied by reduction of autophagic flux [10, 11].
In contrast to APOL1, APOL3 is not secreted [12], and kills intracellular bacteria through detergent-like activity on bacterial membranes [13]. Despite their differential activities, APOL1 and APOL3 share strongly increased expression under inflammatory conditions associated with resistance to infection [3].
Until recently, these observations represented the only salient information available regarding APOL function, apart from pleiotropic cellular toxicity of the APOL1 variants, reported in experimental studies mostly involving ectopic gene expression [14, 15]. Altogether, these observations linked APOLs to cellular killing or toxic activities. However, recent work [16] has uncovered the crucial involvement of APOL1 and APOL3 in intracellular membrane fission and fusion, suggesting that their basic function is not to induce pathogen lysis, but to control membrane dynamics.
APOL1 and APOL3 structure
APOL1 and APOL3 gene transcripts are alternatively spliced in their 5’-terminal region, generating mRNAs variants that encode different isoforms (Fig. 1A). Whereas APOL1 isoform 1 is secreted (with two N-terminal cleavage sites), APOL1 isoform 3 and APOL3 isoform 2 represent the main intracellular versions [11]. The hypothetical structures of APOL1 and APOL3 are schematized in Fig. 1B. The N-terminal domain of secreted APOL1 contains 5 helices including a non-classical four-helix bundle (helices 2–5) that is also present in APOL3 [17]. Helices 2 and 4 correspond to stretches respectively defined as hydrophobic cluster 1 (HC1) and leucine zipper 1 (LZ1) in Uzureau et al. [11]. Downstream from the N-terminal domain, both proteins contain a hydrophobic hairpin helix potentially able to cross a membrane (TM, for transmembrane). In case of APOL1, acidic residues in these helices only allow TM insertion under acidic conditions, these conditions being absolutely required for trypanosome killing [6, 12]. The TM hairpin is immediately adjacent to another helix hairpin termed MAD for Membrane-Addressing Domain, because in experimental studies in Escherichia coli this domain was necessary for membrane association of APOL1 [18]. This domain was also partially protected against protease degradation upon in vitro APOL1 incubation with isolated mitochondrial membranes [6], confirming its tight association with membranes. The MAD domain could be involved in APOL1 and APOL3 binding to cardiolipin [11], the characteristic phospholipid of both bacterial and mitochondrial membranes. Accordingly, APOL1 associates with the mitochondrion when expressed in yeast [19]. After a long hinge sequence (APOL1 A291-A339; APOL3 A232-T272), a second HC-LZ tandem (HC2-LZ2) characterizes the C-terminal region of both APOLs (APOL1 S342-L392; APOL3 G275-L325). In case of APOL1 but not APOL3, the HC2-LZ2 tandem strongly interacts with HC1-LZ1, imposing a specific protein folding that underlies differential trans-interactions of APOL1 with respect to APOL3 [11, 16].
As schematized in Fig. 1B, cis-interaction between the two APOL1 HC-LZ regions prevents HCs exposure. In case of LZ2 deletion or mutations, as occurs for experimental C-terminally truncated APOL1Δ (stop at V353) or natural G1/G2 C-terminal variants respectively, cis-interaction is disrupted and APOL1 hydrophobicity is increased due to HC exposure [11]. This is linked to enhanced APOL1 interaction with APOL3, resulting in APOL3 inactivation phenotypically mimicking APOL3 deletion [11]. Under acidic conditions as in trypanosome endosomes, APOL1 can insert into membranes and cis-interaction between the two HC-LZ regions is lost [11, 16]. In endosomes of T. b. rhodesiense, the HC2-LZ2 tandem interacts with the Serum Resistance-Associated protein SRA, which neutralizes APOL1 and prevents trypanosome lysis [4, 5]. In APOL3, no cis-interaction between HC-LZ regions occurs, but LZ2 may interact with helix 5 [16]. In striking contrast with APOL1, APOL3 tightly binds to the Ca2+ sensor protein NCS1 and the PI4KB kinase, and this involves HC1 [16]. However, C-terminal APOL1 variants can bind to PI4KB, owing to increased HC1 exposure (strongly for APOL1Δ, weakly for G1 or G2) [16].
APOL1 and APOL3 pore-forming activity
In helix 5, APOL1 and APOL3 contain a peptide resembling the BCL-homology-3 (BH3) motif typical of the apoptotic BCL2 (B-cell lymphoma 2) family, and like BCL2 family members, APOL1 and APOL3 contain a TM hairpin responsible for in vitro membrane pore-forming and cellular killing activities [6, 11, 12, 18]. In trypanosomes, APOL1 and APOL3 induce apoptotic-like cell lysis due to permeabilization of the parasite mitochondrial membrane followed by translocation of a mitochondrial endonuclease into the nucleus, causing DNA fragmentation [6, 12]. Interestingly, APOL1- and APOL3-mediated trypanosome killing is accompanied by increased fusion between mitochondrial membranes [6, 12]. In either mouse dendritic cells or human podocytes, APOL1 and APOL3 are involved in apoptosis induced by interferon-I (IFN-I)-mediated inflammation [11, 20]. Given the key involvement of the mitochondrial membrane in apoptosis, the activity of these APOLs is thus linked to modifications of this membrane.
Cell culture studies, mostly involving ectopic APOL1 expression, suggested that intracellular APOL1 variants trigger pleiotropic toxicity [14, 15]. However, experimental artefacts linked to APOL1 overexpression and/or mislocalization cast important doubts regarding the physiological relevance of these observations [3, 21,22,23]. Intracellular APOL1 activities are distinct from extracellular ones, because these activities are performed by different APOL1 isoforms, at different pHs and with a different topology with respect to the target membrane [22]. In trypanosomes, APOL1 killing activity was clearly due to the central hairpin helix, whose transmembrane insertion requires a low pH [6, 12]. In trypanosome endosomes, APOL1 triggers weak transmembrane anionic fluxes responsible for lysosome swelling [18], but under neutral conditions the APOL1 pore exhibits strong cationic conductance ascribed to negatively charged residues present in HC2 [24, 25]. Therefore, it was proposed that the HC2-LZ2 region is involved in cation conductance at the plasma membrane after prior HC2 insertion into endosomal membranes [26, 27]. Transmembrane HC2 insertion can only occur under acidic conditions because it requires protonation of the acidic HC2 residues, coupled to acidic pH-mediated disruption of cis-interaction between the two HC-LZ tandems [16, 22]. However, such insertion is hardly compatible with the known presentation of HC2-LZ2 in the lumen of trypanosome endosomes, where this helix tandem can interact with the N-terminal helix A of T. b. rhodesiense SRA, as determined by both experimental evidence and in silico modelling [4, 22] (Fig. 2). Moreover, the strong membrane disrupting activity of HC2 [4] is unlikely to allow stable channel formation in the plasma membrane. Finally, transmembrane HC2 insertion cannot occur at neutral pH in APOL3, and this impossibility does not prevent APOL3 from exhibiting fully pH-independent cationic pore-forming activity in vitro, as well as fully pH-independent trypanosome-killing ability [12]. Therefore, cationic selectivity of the pore could result not from membrane insertion of HC2, but from positioning of conserved HC2 acidic residues close to the cytoplasmic pore entry site, which would be affected by either HC2-LZ2 interaction with SRA or LZ2 deletion as occurs in APOL1Δ [22]. Irrespective of the eventual transmembrane insertion of HC2, APOL1 ionic pore-forming activity is unlikely to account for the specific effects of APOL1 variants in podocytes because intracellular APOL1 was not detected within podocyte acidic compartments. In vitro, a twofold difference of K+ pore-forming activity was identified between wild-type (WT) APOL1 and C-terminal variants [28], but whether such difference is sufficient for inducing in vivo toxicity remains uncertain.
Contrasting with experiments involving ectopic APOL1 expression, studies involving CRISPR/Cas9-mediated gene editing in podocytes did not reveal generalized toxicity of the C-terminally-truncated APOL1 variant APOL1Δ. These studies rather revealed changes in organization of actomyosin linked to reduction of Golgi PI4KB activity, with effects on cell shape and motility as well as on Golgi and mitochondrion structure. This phenotype strikingly resembled that of natural G1- or G2-expressing podocytes, albeit with increased severity as expected from the difference between full LZ2 deletion and only mutations [11]. APOL1Δ strongly reduced apoptosis and inhibited in vitro pore-forming activity of APOL3-NCS1 complex following direct interaction with this complex [11]. Importantly, APOL1Δ did not exert ionic pore-forming activity in vitro or cellular toxicity in trypanosomes [11, 24, 29], clearly indicating that the severe G1/G2-like phenotype of APOL1Δ-expressing podocytes cannot be ascribed to APOL1-driven ionic pore formation. Consistently, trypanosome-killing activity of APOL1 or APOL3 appeared to result not from cationic fluxes, but from mitochondrial megapore formation, as occurs for apoptosis in higher eukaryotic cells [6, 12, 22]. Along this line, like APOL1 or APOL3 the apoptotic BCL2 family members also exhibit ionic pore-forming activity in vitro and cellular toxicity upon ectopic expression, but in vivo these proteins form lipidic rather than proteinaceous oligomeric pores, and so far, no evidence involves ionic pore-forming activity in apoptosis [30, 31].
A recent model of APOL1-mediated podocytopathy proposes that upon IFN-I signalling, cationic pores formed by APOL1 variants at the plasma membrane induce intracellular Ca2+ fluxes through activation of G protein-coupled receptors (GPCR) and inositol 1,4,5-trisphosphate receptors (IP3R) [32]. However, the existence of plasma membrane APOL1 pores remains to be demonstrated, and the surface cationic fluxes were not proven to occur through such pores. Since both NCS1 and the PI4KB product phosphatidylinositol-4-phosphate (PI4P) are involved in cation channel activity at the plasma membrane, including K+ efflux by Kv4 channels [33,34,35], delocalizing PI4KB and NCS1 activities from the Golgi as occurs upon APOL3-PI4KB complex disruption [11, 16] could affect surface cation fluxes independently of APOL1 pores. In addition, and importantly, the intracellular Ca2+ fluxes could result not from APOL1 pore activity, but from increased NCS1 binding to GPRCs and GPCR kinases [36,37,38,39] as well as NCS1 binding to IP3Rs, including at endoplasmic reticulum-mitochondrion contact sites (MERCSs) [33, 39, 40]. Indeed, NCS1 controls the activity of both receptor types, and NCS1 delocalization from the Golgi may alter the activity of these receptors at both plasma and endoplasmic reticulum membranes. The demonstration that the APOL1 inhibitor VX-147 prevents both APOL1 variant-induced toxicity and K+ fluxes [32] does not prove that APOL1 variant-driven cationic pore formation is responsible for kidney disease, because VX-147 has not been demonstrated to specifically block the APOL1 pore, but could alternatively interfere with APOL1 folding, interactions and/or stability, inhibiting other processes affected by APOL1 variants.
In conclusion, APOL1 cationic pore-forming activity can be observed in vitro, but is unlikely to occur at the plasma membrane in vivo, and all phenotypic consequences of APOL1 C-terminal variants expression can be explained by the effects of APOL3 inactivation on PI4KB and NCS1 trafficking, rather than APOL1 pore-forming activity. Thus, kidney disease induced by APOL1 risk variants may result not from intrinsic APOL1 toxicity, but rather from improper cell function and consecutive inflammatory reaction.
APOL3 controls membrane fission through interaction with PI4KB
Strikingly contrasting with APOL1, APOL3 was found to exhibit high-affinity interactions with PI4KB, NCS1, CALN1 and ADP-ribosylation-factor-1 (ARF1) [16]. All these proteins participate in PI4P synthesis at the trans-Golgi, NCS1 and CALN1 respectively increasing and decreasing PI4KB activity depending on the presence of Ca2+ [41]. APOL3, but not NCS1, stimulated in vitro PI4KB activity provided Ca2+ was present, and conversely CALN-1 inhibited PI4KB in the absence of Ca2+ [16]. In vivo, NCS1 or CALN1 interaction with APOL3 may allow their association with the Golgi membrane, NCS1 providing the local Ca2+ needed for PI4KB activation by APOL3. Together with factors controlling vesicle shaping and trafficking, the different proteins interacting with APOL3 participate in secretion and exocytosis (Fig. 3). These processes are influenced by interferon-I (IFN-I) signalling, as occurs upon viral infection. IFN-I-induced Immunity-related-GTPase-family-M-1 (IRGM1) triggers both Golgi fragmentation and autophagy through activation of the AMP-activated-protein-kinase (AMPK), which phosphorylates both the Golgi-specific-brefeldin-A-resistance-guanine-nucleotide-exchange-factor-1 (GBF1) and the Autophagy-1 kinase (ATG1) [42]. While GBF1 induces ARF1 dissociation from ADP-ribosylation-factor-GTPase-activating protein-1 (ARFGAP1) and activates ARF1 (GTP binding), ATG1 initiates autophagy at MERCS pre-autophagosomal structures, inducing the coalescence of Golgi-derived vesicles carrying the lipid scramblase autophagy-related-protein-9A (ATG9A). At the Golgi, ARF1 activation promotes its membrane recruitment and increased binding to PI4KB, possibly disrupting APOL3 interaction with the PI4KB/NCS1 complex [16]. IFN-I signalling results in PI4KB/NCS1/ARF1 delocalization from the Golgi and trafficking to the mitochondrion in vesicles carrying ATG9A together with APOL1 and APOL3, in a process triggering mitophagy (Fig. 4) [3, 16].
In human podocytes, either natural or CRISPR/Cas9-mediated APOL3 KO mimicked the G1/G2 phenotype, but with higher severity [11, 43]. Absence of APOL3 led to strong reduction of PI4KB activity at the Golgi, Golgi shrinkage and concomitant reduction of mitochondrial membrane fission [11, 16]. I propose that this phenotype results from PI4KB transfer to the mitochondrion following PI4KB release from the Golgi membrane like occurs upon ARF1 activation, but with reduced PI4KB fission-inducing activity due to lack of ARF1 activation (Fig. 4). Indeed, PI4KB is required with ARF1 for mitochondrial membrane fission [44,45,46,47,48,49]. Accordingly, the involvement of IP3R-induced Ca2+ efflux in triggering mitochondrial fission at MERCSs [40, 50] probably reflects NCS1/Ca2+-mediated activation of PI4KB. The PI4KB product PI4P binds to the NM2A myosin and membrane-bending factors linked to actin polymerization at the fission site [44, 51,52,53]. PI4P can oligomerize into lipid raft-like domains that recruit Golgi-phosphoprotein-3 (GOLPH3), a trans-Golgi and mitochondrial protein binding to the F-actin and NM2A binder myosin-18A (MYO18) to generate a pulling force for membrane fission [54,55,56]. Other potential PI4P-binding fission components involved in auto/mitophagy include fission-1 (FIS1) and syntaxin-17 (STX17) [57,58,59,60].
I conclude that PI4KB activity conditions membrane fission at the Golgi and mitochondrion, in a process controlled by APOL3 and activated ARF1, at the Golgi and mitochondrion respectively.
C-terminal APOL1 variants disrupt APOL3-PI4KB interaction at the Golgi
The APOL1 C-terminal variants (natural G1 and G2, or experimental APOL1Δ) were found to exhibit increased binding to both APOL3 and PI4KB, affecting the interaction of APOL3 with PI4KB and therefore, reducing Golgi PI4P synthesis by PI4KB [11, 16]. Binding to PI4KB may trigger its release from Golgi membrane anchoring because unlike APOL3, the APOL1 variants cannot insert into membranes at a neutral pH. Accordingly, in APOL1Δ-expressing podocytes PI4KB was dissociated from APOL3, mimicking the effect of APOL3 KO [11]. Thus, APOL1 unfolding due to alteration or deletion of the C-terminal LZ2, as occurs in G1, G2 or APOL1Δ podocytes, results in relative disruption of APOL3-PI4KB interaction, inducing a similar dysfunctional phenotype linked to PI4KB delocalization from the Golgi, although with differing intensities.
Mitochondria appeared to fragment upon either APOL3 KO or APOL1Δ, G1 or G2 expression, suggesting that APOL3 loss or inactivation triggers mitochondrial fission [11, 61]. While consistent with the view that PI4KB delocalizes to the mitochondrion upon disruption of the APOL3-PI4KB complex, this observation seems to contradict the proposal presented in the previous paragraph, that under these conditions, the PI4KB fission-inducing activity is reduced due to lack of ARF1 activation. The data presented in Lecordier et al. [16] provide an explanation for this apparent discrepancy: mitochondrial fragmentation in APOL3 KO or APOL1Δ cells does not result from increased fission, but from accumulation of non-digested mitophagosomes (see below).
APOL3 induces membrane fusion through interaction with VAMP8
In either APOL3 KO or APOL1Δ-expressing podocytes, the mitophagy flux was found to be reduced not only because of decreased mitochondrion fission, but also because of decreased mitophagosome fusion with endolysosomes, leading to the accumulation of dark, convoluted and multilamellar mitophagosomes, particularly in APOL1Δ cells [16]. Decreased vesicle fusion following APOL3 inactivation suggested that APOL3 is involved in membrane fusion. Accordingly, increased mitochondrial membrane fusion was observed following the uptake of APOL3 or APOL1 in trypanosomes [6, 12] and APOL3 exhibited fusion activity on membranes of intracellular bacteria [13]. Thus, APOL3 and APOL1 appear to induce membrane fusion. Accordingly, the C-terminal domain of APOL1 can bind to the fusogenic protein VAMP8 [62], and in trypanosomes, a VAMP8 homologue (TbVAMP7B) is involved in APOL1 trypanosome-killing activity [63]. Furthermore, APOL3 can interact with the soluble-N-ethylmaleimide-sensitive-factor-attachment-receptor (SNARE) domain of VAMP8 or the R-SNARE helix of TbVAMP7B, and interaction of the APOL3 helices 4–5 and MAD1-2 with VAMP8 can promote the fusion between liposome vesicles respectively containing mitochondrial-like and endosomal-like membrane lipids [16]. In these experiments, APOL1 was unable to promote vesicle fusion with VAMP8-containing vesicles, unless a preincubation at low pH allowed its membrane insertion [16]. Thus, despite its membrane fusion potential, APOL1 cannot exert this activity unless transferred to acidic conditions. Accordingly, only APOL3, and not APOL1, was found to kill intracellular bacteria [13]. This process is likely to involve VAMP8 for bacterial digestion in endolysosomes.
STX17 was identified as VAMP8 partner for the fusion between autophagosomes and endolysosomes [64], but the VAMP8 partner for the fusion between mitophagosomes and endolysosomes remained unknown [65]. I propose that APOL3 fulfils this function (Fig. 4). APOL3 could be recruited to the mitophagosome membrane through interaction with cardiolipin [66, 67], which promotes APOL3/VAMP8-mediated fusion [16]. APOL3 shares several characteristics of STX17. Both proteins contain a double-stranded TM hairpin with high flexibility, due to an important proportion of helix-breaking amino acids [16]. Hydrophobic helix flexibility is crucial for the ability of TM peptides to drive membrane fusion [68], and may explain the detergent-like fusion activity of APOL3 on bacterial membranes [13]. Additional similarities between STX17 and APOL3 include Golgi-to-mitochondrion trafficking and activity in both mitochondrion fission and mitophagy initiation [59, 60, 69].
APOL1 controls PI4KB and APOL3 traffic
APOL1 co-localizes with PI4KB and APOL3 in ATG9A vesicles [16], known to traffic PI4KB from the Golgi to the mitochondrion for autophagy initiation, which occurs together with mitochondrion fission at MERCSs [44, 70]. Moreover, APOL1 tightly associates with NM2A, the myosin known to be responsible for ATG9A vesicle trafficking [11, 71,72,73]. Finally, APOL1 can bind to prohibitin-2 (PHB2) [16], a mitophagy receptor involved in IFN-I-mediated autophagy together with GOLPH3 [74,75,76].
In APOL1 KO cells, Golgi PI4KB activity and actomyosin organization were not affected, indicating that APOL1 plays no significant role in PI4KB control at the Golgi [11]. However, in these cells mitochondrion fission and mitophagy were inhibited, suggesting that APOL1 is involved in both PI4KB and APOL3 transfer to the mitochondrion [16]. APOL1 association with NM2A may allow PI4KB/APOL3 traffic to the mitochondrion, and APOL1 binding to PHB2 could target PI4KB/APOL3 to MERCSs.
Consistent with these considerations, in APOL1 + 3 KO cells the mitochondrial phenotype linked to APOL3 deletion was also reverted [11], demonstrating the requirement of APOL1 for mitochondrial targeting of PI4KB. In these cells, the absence of APOL1 restored PI4KB activity at the Golgi, albeit at a slightly reduced level [11]. Therefore, preventing PI4KB delocalization still allows Golgi PI4KB activity despite APOL3 absence. Collectively, these observations suggest that the most important function of APOL3 is not PI4KB activity control, but PI4KB/NCS1 sequestration at the Golgi membrane, opposing to PI4KB/NCS1 delocalization by APOL1.
In APOL1Δ-expressing podocytes, PI4KB and NCS1 clearly delocalized from APOL3 and the Golgi, but remained strongly associated [11]. PI4KB and APOL1 are present in Golgi-derived ATG9A vesicles that are trafficking to various compartments such as MERCSs, the plasma membrane and endosomes [44, 77], and NCS1 was also detected in Golgi-derived vesicles trafficking to the plasma membrane [78]. Thus, through disruption of PI4KB-APOL3 interaction the C-terminal APOL1 variants may increase PI4KB and NCS1 trafficking to different membranes, including the plasma membrane, therefore inducing pleiotropic changes of membrane dynamics.
The murine APOL3 and APOL1 homologues
Based on both overall sequence identity and relative pH dependence of transmembrane insertion, mAPOL8 and mAPOL9 are the best homologue candidates for APOL3 and APOL1 respectively (Fig. 5). Like APOL3, mAPOL8 could interact with NCS1, because mAPOL8 upregulation promotes synapse formation by neural stem cells [79], suggesting increased NCS1 activity [80]. Since the transgenic expression of the APOL1 G1 and G2 variants in mice can induce kidney disease [10], I propose that mAPOL8 is the mouse APOL family member inactivated by the APOL1 variants. Like APOL1, mAPOL9 is induced by IFN-I and is involved in restriction of viral infection [2, 81]. Moreover, like APOL1, mAPOL9 binds to PHB2 [2, 16]. However, contrasting with APOL1, mAPOL9 lacks a signal peptide, and is therefore only intracellular, in keeping with the primate specificity of APOL1 trypanosome-killing activity.
Concluding remarks: kidney disease and other perspectives
The proposal that APOL3 and APOL1 control intracellular membrane dynamics provides explanations for kidney disease induced by APOL1 G1/G2 expression. Indeed, APOL3 inactivation by APOL1 C-terminal variants leads to drastic actomyosin reorganization, which influences kidney function notably through changes in podocyte shape and motility. I propose that APOL1 C-terminal variants can affect membrane dynamics in various cellular compartments, due to increased trafficking of PI4KB and NCS1 from the Golgi to other membranes. Changes in surface membrane dynamics could trigger effacement of podocyte foot processes and consecutive impairment of kidney activity. Kidney function is also particularly affected by interference with mitochondrial membrane fission [82], which reduces IFN-I-induced mitophagy and leads to mitochondrion dysfunctions together with exacerbated inflammatory reaction. Both effects on actomyosin organization and auto/mitophagy flux are characteristic of APOL1 variants-linked kidney disease, either genuine in humans or transgenic in mice or Drosophila melanogaster lines [10, 11, 83].
As a therapeutic perspective against this disease, disruption of APOL1 G1/G2 hydrophobic interactions with APOL3 could be attempted using either synthetic peptides of the interacting helices, lipid droplets [84] or overexpressed VAMP8 [85]. Alternatively, given the relative absence of dysfunctional phenotype in APOL1 KO cells [11, 16, 86], APOL1 inactivation could treat the disease [32, 87, 88]. However, APOL1 being involved in induction of mitophagy, APOL1 inactivation could reduce the ability to resist viral infection.
In addition to kidney disease, APOL1 or APOL3 variants could participate in other pathologies like neurotransmission disorders or cancer metastasis, which both involve NCS1 activity and membrane dynamics [3].
Possible future research directions also include the following:
-
Function of other APOLs? Different APOL family members may play membrane-related functions in distinct organelles. For instance, in mouse lipid droplets, mAPOL6, a distant family member devoid of NCS1- and PI4KB-interacting helices, promotes triglyceride accumulation through the activity of its specific C-terminal region [89]. While involved in lipid droplet expansion under high fat diet, mAPOL6 strongly associates with myosin-10 (MYH10) and actomyosin components (Fig. 6), suggesting a function linking organelle size control with membrane dynamics (C. Vermeiren and E. Pays: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/279701.). Consistently, MYH10 was found to govern both adipocyte adipogenesis and PI4P-mediated lipid droplet dynamics [90, 91]. In mAPOL7s, extensive acidic sequence insertions suggest a role in acidic environments, particularly under inflammatory conditions [20].
-
APOLs function in other membranes? Apart from Golgi, mitochondrion and lipid droplet membranes, APOLs may also control the dynamics of the plasma membrane. This is suggested by the pleiotropic functions of APOL3-controlled NCS1, which affects surface channels and GPCR activities, exocytosis and synapse formation [33,34,35,36,37,38,39,40]. Moreover, since APOL3 is involved in mitophagosome fusion with endolysosomes, APOL3 could be involved in lysosome membrane dynamics, which is also supported by some PI4KB association with lysosomes [92]. Since virus-induced inflammation involves PI4KB-mediated transport of Stimulator of IFN Genes (STING) from Golgi to endosomes [93], APOLs could accompany PI4KB trafficking to endosomal membranes.
-
APOL1 interaction with NM2A? The tight co-immunolocalization and stoichiometric immunoprecipitation of APOL1 with all three NM2A subunits myosin heavy chain 9 (MYH9), regulatory light chain (RLC) and essential light chain (ELC) (both light chains being NCS1-like proteins) suggest that APOL1 directly interacts with NM2A [11]. Accordingly, APOL1 can bind in vitro to the MYL12A RLC (J.H. Graversen and E. Pays, unpublished data).
-
APOL translocation across endosomal membranes? Given the APOL similarities with SNARE proteins such as STX17, particularly in the flexible TM hairpin, it is relevant to note that membrane translocation has been reported for STX2 (epimorphin) and STX4 [94, 95]. Therefore, after endocytosis in trypanosomes APOL1 could hypothetically translocate from the luminal to the cytoplasmic face of the endosomal membrane to promote fusion between endosomes and mitochondrion, and/or between mitochondrial membranes (mitochondrion fenestration).
-
APOL control of gene expression? PI4KB, APOL1 and APOL3 contain nuclear localization signals and are present in both nucleus and cytoplasm [11, 16, 96, 97]. Moreover, nuclear PI4KB and PI4P are associated with mRNA speckles and factors involved in pre-mRNA splicing or transport [98, 99], and both APOL1 and mAPOL9 immunoprecipitates contain RNA processing components [2, 11]. Thus, APOL1, APOL3 and PI4KB may influence gene expression. Consistently, NCS1 deficiency was reported to affect the mRNA levels of genes involved in mitochondrial activity [100].
-
APOL3 analogue in yeast? Whereas NCS1 exhibits extensive structural and functional similarities with yeast FRQ1 [101], there is no yeast APOL homologue, suggesting that either FRQ1 activates PIK1 directly or FRQ1 binds to an APOL3-like protein. Along this line, Saccharomyces cerevisiae USE1 shares key APOL3 features: this protein with a highly flexible transmembrane span can interact with FRQ1, exhibits an unusual SNARE structure, and is involved in Golgi to endoplasmic reticulum vesicle traffic [102; https://yeastrc.org/pdr/viewY2HScreen.do?ID=97]. Interestingly, human USE1 can interact with APOL2 (https://www.ebi.ac.uk/intact/details/interaction/EBI-23699537).
Availability of data and material
Not applicable.
References
Page NM, Butlin DJ, Lomthaisong K, Lowry PJ (2001) The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 74:71–78. https://doi.org/10.1006/geno.2001.6534
Kreit M, Vertommen D, Gillet L, Michiels T (2015) The interferon-inducible mouse Apolipoprotein L9 and prohibitins cooperate to restrict Theiler’s virus replication. PLoS One 10:e0133190. https://doi.org/10.1371/journal.pone.0133190
Pays E (2021) The function of Apolipoproteins L (APOLs): relevance for kidney disease, neurotransmission disorders, cancer and viral infection. FEBS J 288:360–381. https://doi.org/10.1111/febs.15444
Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane JP, De Baetselier P, Brasseur R, Pays E (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422:83–87. https://doi.org/10.1038/nature01461
Pays E, Vanhollebeke B, Uzureau P, Lecordier L, Pérez-Morga D (2014) The molecular arms race between African trypanosomes and humans. Nat Rev Microbiol 12:575–584. https://doi.org/10.1038/nrmicro3298
Vanwalleghem G, Fontaine F, Lecordier L, Tebabi P, Klewe K, Nolan DP, Yamaryo-Botté Y, Botté C, Kremer A, Burkard GS, Rassow J, Roditi I, Pérez-Morga D, Pays E (2015) Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1. Nat Commun 6:8078. https://doi.org/10.1038/ncomms9078
Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski KA, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak M (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841–845. https://doi.org/10.1126/science.1193032
Cooper A, Ilboudo H, Alibu VP, Ravel S, Enyaru J, Weir W, Noyes H, Capewell P, Camara M, Milet J, Jamonneau V, Camara O, Matovu E, Bucheton B, MacLeod A (2017) APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife 6:e25461. https://doi.org/10.7554/eLife.25461
Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K (2010) Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128:345–350. https://doi.org/10.1007/s00439-010-0861-0
Beckerman P, Bi-Karchin J, Park ASD, Qiu C, Dummer PD, Soomr I, Boustany-Kari CM, Pullen SS, Miner JH, Hu C-AA, Rohacs T, Inoue K, Ishibe S, Saleem MA, Palmer MB, Cuervo AM, Kopp JB, Susztak K (2017) Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med 23:429–438. https://doi.org/10.1038/nm.4287
Uzureau S, Lecordier L, Uzureau P, Hennig D, Graversen JH, Homblé F, Ekulu Mfutu P, Oliveira Arcolino F, Raquel Ramos A, La Rovere RM, Luyten T, Vermeersch M, Tebabi P, Dieu M, Cuypers B, Deborggraeve S, Rabant M, Legendre C, Moestrup SK, Levtchenko E, Bultynck G, Erneux C, Pérez-Morga D, Pays E (2020) APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin. Cell Rep 30:3821–3836. https://doi.org/10.1016/j.celrep.2020.02.064
Fontaine F, Lecordier L, Vanwalleghem G, Uzureau P, Van Reet N, Fontaine M, Tebabi P, Vanhollebeke B, Buscher P, Pérez-Morga D, Pays E (2017) APOLs with low pH dependence can kill all African trypanosomes. Nat Microbiol 2:1500–1506. https://doi.org/10.1038/s41564-017-0034-1
Gaudet RG, Zhu S, Halder A, Kim B-H, Bradfield CJ, Huang S, Xu D, Mamiñska A, Nguyen TN, Lazarou M, Karatekin E, Gupta K, MacMicking JD (2021) A human apolipoprotein L with detergent-like activity kills intracellular pathogens. Science 373:6552–8113. https://doi.org/10.1126/science.abf8113
Kruzel-Davila E, Shemer R, Ofir A, Bavli-Kertselli I, Darlyuk-Saadon I, Oren-Giladi P, Wasser WG, Magen D, Zaknoun E, Schuldiner M, Salzberg A, Kornitzer D, Marelja Z, Simons M, Skorecki K (2017) APOL1-mediated cell injury involves disruption of conserved trafficking processes. J Am Soc Nephrol 28:1117–1130. https://doi.org/10.1681/ASN.2016050546
Daneshpajouhnejad P, Kopp JB, Winkler CA, Rosenberg AZ (2022) The evolving story of apolipoprotein L1 nephropathy: the end of the beginning. Nat Rev Nephrol 18:307–320. https://doi.org/10.1038/s41581-022-00538-3
Lecordier L, Heo P, Graversen JH, Hennig D, Skytthe MK, Cornet d’Elzius A, Pincet F, Pérez-Morga D, Pays E (2023) Apolipoproteins L1 and L3 control mitochondrial membrane dynamics. Cell Rep 42:113528. https://doi.org/10.1016/j.celrep.2023.113528
Ultsch M, Holliday MJ, Gerhardy S, Moran P, Scales SJ, Gupta N, Oltrabella F, Chiu C, Fairbrother W, Eigenbrot C, Kirchhofer D (2021) Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif. Commun Biol 4:916. https://doi.org/10.1038/s42003-021-02387-5
Pérez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Homblé F, Vanhamme L, Tebabi P, Pays A, Poelvoorde P, Jacquet A, Brasseur R, Pays E (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309:469–472. https://doi.org/10.1126/science.1114566
Chidiac M, Daher J, Boeckstaens M, Poelvoorde P, Badran B, Marini AM, Khalaf R, Vanhamme L (2020) Human apolipoprotein L1 interferes with mitochondrial function in Saccharomyces cerevisiae. Mol Med Rep 22:1910–1920. https://doi.org/10.3892/mmr.2020.11271
Uzureau S, Coquerelle C, Vermeiren C, Uzureau P, Van Acker A, Pilotte L, Monteyne D, Acolty V, Vanhollebeke B, Van den Eynde B, Pérez-Morga D, Moser M, Pays E (2016) Apolipoproteins L control cell death triggered by TLR3/TRIF signalling in dendritic cells. Eur J Immunol 46:1854–1866. https://doi.org/10.1002/eji.201546252
O’Toole JF, Schilling W, Kunze D, Madhavan SM, Konieczkowski M, Gu Y, Luo L, Wu Z, Bruggeman LA, Sedor JR (2018) ApoL1 overexpression drives variant-independent cytotoxicity. J Am Soc Nephrol 29:869–879. https://doi.org/10.1681/ASN.2016121322
Pays E (2022) Distinct APOL1 functions in trypanosomes and kidney podocytes. Trends Parasitol 38:104–108. https://doi.org/10.1016/j.pt.2021.11.005
Yoshida T, Latt KZ, Heymann J, Kopp JB (2021) Lessons from APOL1 animal models. Front Med 8:762901. https://doi.org/10.3389/fmed.2021.762901
Thomson R, Finkelstein A (2015) Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis. Proc Natl Acad Sci USA 112:2894–2899. https://doi.org/10.1073/pnas.1421953112
Schaub C, Verdi J, Lee P, Terra N, Limon G, Raper J, Thomson R (2020) Cation channel conductance and pH gating of the innate immunity factor APOL1 are governed by pore-lining residues within the C-terminal domain. J Biol Chem 295:13138–13149. https://doi.org/10.1074/jbc.RA120.014201
Schaub C, Lee P, Racho-Jansen A, Giovinazzo J, Terra N, Raper J, Thomson R (2021) Coiled-coil binding of the leucine zipper domains of APOL1 is necessary for the open cation channel conformation. J Biol Chem 297:101009. https://doi.org/10.1016/j.jbc.2021.101009
Giovinazzo JA, Thomson RP, Khalizova N, Zager PJ, Malani N, Rodriguez-Boulan E, Raper J, Schreiner R (2020) Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity. Elife 9:e51185. https://doi.org/10.7554/eLife.51185
Bruno J, Edwards JC (2021) Kidney-disease-associated variants of Apolipoprotein L1 show gain of function in cation channel activity. J Biol Chem 296:100238. https://doi.org/10.1074/jbc.RA120.013943
Lecordier L, Vanhollebeke B, Poelvoorde P, Tebabi P, Paturiaux-Hanocq F, Andris F, Lins L, Pays E (2009) C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog 5:e1000685. https://doi.org/10.1371/journal.ppat.1000685
Westphal D, Dewson G, Menard M, Frederick P, Iyer S, Bartolo R, Gibson L, Czabotar PE, Smith BJ, Adams JM, Kluck RM (2014) Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane. Proc Natl Acad Sci USA 111:E4076–E4085. https://doi.org/10.1073/pnas.1415142111
Uren RT, Iyer S, Kluck RM (2017) Pore formation by dimeric Bak and Bax: an unusual pore? Philos Trans R Soc Lond B Biol Sci 372:20160218. https://doi.org/10.1098/rstb.2016.0218
Datta S, Antonio BM, Zahler NH, Theile JW, Krafte D, Zhang H, Rosenberg PB, Chaves AB, Muoio DM, Zhang G, Silas D, Li G, Soldano K, Nystrom S, Ferreira D, Miller SE, Bain JR, Muehlbauer MJ, Ilkayeva O, Becker TC, Hohmeier HE, Newgard CB, Olabisi OA (2024) APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease. J Clin Invest. https://doi.org/10.1172/JCI172262
Nakamura TY, Nakao S, Wakabayashi S (2019) Emerging roles of neuronal Ca2+ sensor-1 in cardiac and neuronal tissues: a mini review. Front Mol Neurosci 12:56. https://doi.org/10.3389/fnmol.2019.00056
Dickson EJ, Jensen JB, Hille B (2014) Golgi and plasma membrane pools of PI(4)P contribute to plasma membrane PI(4,5)P2 and maintenance of KCNQ2/3 ion channel current. Proc Natl Acad Sci USA 111:E2281-2290. https://doi.org/10.1073/pnas.1407133111
Stojilkovic SS, Balla T (2023) PI(4,5)P2-dependent and -independent roles of PI4P in the control of hormone secretion by pituitary cells. Front Endocrinol 14:1118744. https://doi.org/10.3389/fendo.2023.1118744
Pandalaneni S, Karuppiah V, Saleem M, Haynes LP, Burgoyne RD, Mayans O, Derrick JP, Lian LY (2015) Neuronal calcium sensor-1 binds the D2 dopamine receptor and G-protein-coupled receptor kinase 1 (GRK1) peptides using different modes of interactions. J Biol Chem 290:18744–18756. https://doi.org/10.1074/jbc.M114.627059
Navarro G, Hradsky J, Lluís C, Casadó V, McCormick PJ, Kreutz MR, Mikhaylova M (2012) NCS-1 associates with adenosine A(2A) receptors and modulates receptor function. Front Mol Neurosci 5:53. https://doi.org/10.3389/fnmol.2012.00053
Angelats E, Requesens M, Aguinaga D, Kreutz MR, Franco R, Navarro G (2018) Neuronal calcium and cAMP cross-talk mediated by Cannabinoid CB1 Receptor and EF-Hand calcium sensor interactions. Front Cell Dev Biol 6:67. https://doi.org/10.3389/fcell.2018.00067
Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y, Szigeti-Buck K, Ehrlich BE (2006) Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 116:1668–1674. https://doi.org/10.1172/JCI22466
Angebault C, Fauconnier J, Patergnani S, Rieusset J, Danese A, Affortit CA, Jagodzinska J, Mégy C, Quiles M, Cazevieille C, Korchagina J, Bonnet-Wersinger D, Milea D, Hamel C, Pinton P, Thiry M, Lacampagne A, Delprat B, Delettre C (2018) ER-mitochondria cross-talk is regulated by the Ca2+ sensor NCS1 and is impaired in Wolfram syndrome. Sci Signal 11:eaaq1380. https://doi.org/10.1126/scisignal.aaq1380
Mikhaylova M, Reddy PP, Munsch T, Landgraf P, Suman SK, Smalla KH, Gundelfinger ED, Sharma Y, Kreutz MR (2009) Calneurons provide a calcium threshold for trans-Golgi network to plasma membrane trafficking. Proc Natl Acad Sci USA 106:9093–9098. https://doi.org/10.1073/pnas.0903001106
Hansen MD, Johnsen IB, Stiberg KA, Sherstova T, Wakita T, Richard GM, Kandasamy RK, Meurs EF, Anthonsen MW (2017) Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M. Proc Natl Acad Sci USA 114:E3462–E3471. https://doi.org/10.1073/pnas.1616683114
Skorecki KL, Lee JH, Langefeld CD, Rosset S, Tzur S, Wasser WG, Shemer R, Hawkins GA, Divers J, Parekh RS, Li M, Sampson MG, Kretzler M, Pollak MR, Shah S, Blackler D, Nichols B, Wilmot M, Alper SL, Freedman BI, Friedman DJ (2018) A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Nephrol Dial Transplant 33:323–330. https://doi.org/10.1093/ndt/gfw451
Judith D, Jefferies HBJ, Boeing S, Frith D, Snijders AP, Tooze SA (2019) ATG9A shapes the forming autophagosome through Arfaptin 2 and phosphatidylinositol 4-kinase IIIβ. J Cell Biol 218:1634–1652. https://doi.org/10.1083/jcb.201901115
Nagashima S, Tábara LC, Tilokani L, Paupe V, Anand H, Pogson JH, Zunino R, McBride HM, Prudent J (2020) Golgi-derived PI(4)P-containing vesicles drive late steps of mitochondrial division. Science 367:1366–1371. https://doi.org/10.1126/science.aax6089
Rasmussen ML, Robertson GL, Gama V (2020) Break on through: Golgi-derived vesicles aid in mitochondrial fission. Cell Metab 31:1047–1049. https://doi.org/10.1016/j.cmet.2020.05.010
Tábara LC, Morris JL, Prudent J (2021) The complex dance of organelles during mitochondrial division. Trends Cell Biol 31:241–253. https://doi.org/10.1016/j.tcb.2020.12.005
Terriente-Felix A, Wilson EL, Whitworth AJ (2020) Drosophila phosphatidylinositol-4 kinase fwd promotes mitochondrial fission and can suppress Pink1/parkin phenotypes. PLoS Genet 16:e1008844. https://doi.org/10.1371/journal.pgen.1008844
Boutry M, Kim PK (2021) ORP1L mediated PI4P signalling at ER-lysosome-mitochondrion three-way contact contributes to mitochondrial division. Nat Commun 12:5354. https://doi.org/10.1038/s41467-021-25621-4
Hom J, Yu T, Yoon Y, Porter G, Sheu SS (2010) Regulation of mitochondrial fission by intracellular Ca2+ in rat ventricular myocytes. Biochim Biophys Acta 1797:913–921. https://doi.org/10.1016/j.bbabio.2010.03.018
Chen PW, Billington N, Maron BY, Sload JA, Chinthalapudi K, Heissler SM (2020) The BAR domain of the Arf GTPase-activating protein ASAP1 directly binds actin filaments. J Biol Chem 295:11303–11315. https://doi.org/10.1074/jbc.RA119.009903
Liu X, Shu S, Billington N, Williamson CD, Yu S, Brzeska H, Donaldson JG, Sellers JR, Korn ED (2016) Mammalian nonmuscle myosin II binds to anionic phospholipids with concomitant dissociation of the regulatory light chain. J Biol Chem 291:24828–24837. https://doi.org/10.1074/jbc.M116.739185
Duan X, Wei Y, Zhang M, Zhang W, Huang Y, Zhang YH (2023) PI4P-containing vesicles from Golgi contribute to mitochondrial division by coordinating with polymerized actin. Int J Mol Sci 24:6593. https://doi.org/10.3390/ijms24076593
Ciarlo L, Manganelli V, Matarrese P, Garofalo T, Tinari A, Gambardella L, Marconi M, Grasso M, Misasi R, Sorice M, Malorni W (2012) Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington’s disease. J Lipid Res 53:2057–2068. https://doi.org/10.1194/jlr.M026062
Dippold HC, Ng MM, Farber-Katz SE, Lee SK, Kerr ML, Peterman MC, Sim R, Wiharto PA, Galbraith KA, Madhavarapu S, Fuchs GJ, Meerloo T, Farquhar MG, Zhou H, Field SJ (2009) GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 139:337–351. https://doi.org/10.1016/j.cell.2009.07.052
Kuna RS, Field SJ (2019) GOLPH3: a Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer. J Lipid Res 60:269–275
Wells RC, Hill RB (2011) The cytosolic domain of Fis1 binds and reversibly clusters lipid vesicles. PLoS One 6:e21384. https://doi.org/10.1371/journal.pone.0021384
Arasaki K, Shimizu H, Mogari H, Nishida N, Hirota N, Furuno A, Kudo Y, Baba M, Baba N, Cheng J, Fujimoto T, Ishihara N, Ortiz-Sandoval C, Barlow LD, Raturi A, Dohmae N, Wakana Y, Inoue H, Tani K, Dacks JB, Simmen T, Tagaya M (2015) A role for the ancient SNARE syntaxin 17 in regulating mitochondrial division. Dev Cell 32:304–317. https://doi.org/10.1016/j.devcel.2014.12.011
Xian H, Yang Q, Xiao L, Shen HM, Liou YC (2019) STX17 dynamically regulated by Fis1 induces mitophagy via hierarchical macroautophagic mechanism. Nat Commun 10:2059. https://doi.org/10.1038/s41467-019-10096-1
Kumar S, Gu Y, Abudu YP, Bruun JA, Jain A, Farzam F, Mudd M, Anonsen JH, Rusten TE, Kasof G, Ktistakis N, Lidke KA, Johansen T, Deretic V (2019) Phosphorylation of Syntaxin 17 by TBK1 controls autophagy initiation. Dev Cell 49:130-144.e6. https://doi.org/10.1016/j.devcel.2019.01.027
Ma L, Ainsworth HC, Snipes JA, Murea M, Choi YA, Langefeld CD, Parks JS, Bharadwaj MS, Chou JW, Hemal AK, Petrovic S, Craddock AL, Cheng D, Hawkins GA, Miller LD, Hicks PJ, Saleem MA, Divers J, Molina AJA, Freedman BI (2020) APOL1 kidney-risk variants induce mitochondrial fission. Kidney Int Rep 5:891–904. https://doi.org/10.1016/j.ekir.2020.03.020
Madhavan SM, O’Toole JF, Konieczkowski M, Barisoni L, Thomas DB, Ganesan S, Bruggeman LA, Buck M, Sedor JR (2017) APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8. JCI Insight 2:e92581. https://doi.org/10.1172/jci.insight.92581
Currier RB, Cooper A, Burrell-Saward H, MacLeod A, Alsford S (2018) Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1. PLoS Pathog 14:e1006855. https://doi.org/10.1371/journal.ppat.1006855
Itakura E, Kishi-Itakura C, Mizushima N (2012) The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151:1256–1269. https://doi.org/10.1016/j.cell.2012.11.001
Juhász G (2016) A mitochondrial-derived vesicle HOPS to endolysosomes using Syntaxin-17. J Cell Biol 214:241–243. https://doi.org/10.1083/jcb.201607024
Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, Lippincott-Schwartz J (2010) Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141:656–667. https://doi.org/10.1016/j.cell.2010.04.009
Manganelli V, Capozzi A, Recalchi S, Riitano G, Mattei V, Longo A, Misasi R, Garofalo T, Sorice M (2021) The role of cardiolipin as a scaffold mitochondrial phospholipid in autophagosome formation: in vitro evidence. Biomolecules 11:222. https://doi.org/10.3390/biom11020222
Han J, Pluhackova K, Böckmann RA (2017) The multifaceted role of SNARE proteins in membrane fusion. Front Physiol 8:5. https://doi.org/10.3389/fphys.2017.00005
Muppirala M, Gupta V, Swarup G (2011) Syntaxin 17 cycles between the ER and ERGIC and is required to maintain the architecture of ERGIC and Golgi. Biol Cell 103:333–350. https://doi.org/10.1042/BC20110006
Rühmkorf A, Harbauer AB (2023) Role of mitochondria-ER contact sites in mitophagy. Biomolecules 13:1198. https://doi.org/10.3390/biom13081198
Kruppa AJ, Kendrick-Jones J, Buss F (2016) Myosins, actin and autophagy. Traffic 17:878–890. https://doi.org/10.1111/tra.12410
Tang HW, Wang YB, Wang SL, Wu MH, Lin SY, Chen GC (2011) Atg1-mediated myosin II activation regulates autophagosome formation during starvation-induced autophagy. EMBO J 30:636–651. https://doi.org/10.1038/emboj.2010.338
Wang G, Wang T, Hu Y, Wang J, Wang Y, Zhang Y, Li F, Liu W, Sun Y, Yu B, Kou J (2020) NMMHC IIA triggers neuronal autophagic cell death by promoting F-actin-dependent ATG9A trafficking in cerebral ischemia/reperfusion. Cell Death Dis 11:428. https://doi.org/10.1038/s41419-020-2639-1
Wei Y, Chiang WC, Sumpter R Jr, Mishra P, Levine B (2017) Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell 168:224-238.e10. https://doi.org/10.1016/j.cell.2016.11.042
Qi A, Lamont L, Liu E, Murray SD, Meng X, Yang S (2023) Essential protein PHB2 and its regulatory mechanisms in cancer. Cells 12:1211. https://doi.org/10.3390/cells12081211
Wang K, Qi Y, Wang X, Liu Y, Zhao M, Zhou D, Zhang Y, Wang Y, Yu R, Zhou X (2021) GOLPH3 promotes glioma progression by enhancing PHB2-mediated autophagy. Am J Cancer Res 11:2106–2123 (PMCID: PMC8167689)
Meng Y, Luo Q, Chen Q, Zhu Y (2023) A noncanonical autophagy function of ATG9A for Golgi integrity and dynamics. Autophagy 19:1607–1608. https://doi.org/10.1080/15548627.2022.2131244
Vashi N, Andrabi SB, Ghanwat S, Suar M, Kumar D (2017) Ca2+-dependent focal exocytosis of Golgi-derived vesicles helps phagocytic uptake in macrophages. J Biol Chem 292:5144–5165. https://doi.org/10.1074/jbc.M116.743047
Xue W, Zhang H, Fan Y, Xiao Z, Zhao Y, Liu W, Xu B, Yin Y, Chen B, Li J, Cui Y, Shi Y, Dai J (2021) Upregulation of Apol8 by epothilone D facilitates the neuronal relay of transplanted NSCs in spinal cord injury. Stem Cell Res Ther 12:300. https://doi.org/10.1186/s13287-021-02375-w
Chen XL, Zhong ZG, Yokoyama S, Bark C, Meister B, Berggren PO, Roder J, Higashida H, Jeromin A (2001) Overexpression of rat neuronal calcium sensor-1 in rodent NG108-15 cells enhances synapse formation and transmission. J Physiol 532:649–659. https://doi.org/10.1111/j.1469-7793.2001.0649e.x
Taylor HE, Khatua AK, Popik W (2014) The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol 88:592–603. https://doi.org/10.1128/JVI.02828-13
Qin L, Xi S (2022) The role of mitochondrial fission proteins in mitochondrial dynamics in kidney disease. Int J Mol Sci 23:14725. https://doi.org/10.3390/ijms232314725
Zhu JY, Lee JG, Fu Y, van de Leemput J, Ray PE, Han Z (2023) APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway. Dis Model Mech 16:dmm050223. https://doi.org/10.1242/dmm.050223
Chun J, Zhang JY, Wilkins MS, Subramanian B, Riella C, Magraner JM, Alper SL, Friedman DJ, Pollak MR (2019) Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity. Proc Natl Acad Sci USA 116:3712–3721. https://doi.org/10.1073/pnas.1820414116
Lee JG, Fu Y, Zhu JY, Wen P, van de Leemput J, Ray PE, Han Z (2023) A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes. Cell Biosci 13:199. https://doi.org/10.1186/s13578-023-01147-8
Vanhollebeke B, Truc P, Poelvoorde P, Pays A, Joshi PP, Katti R, Jannin JG, Pays E (2006) Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. N Engl J Med 355:2752–2756. https://doi.org/10.1056/NEJMoa063265
Choy J, Kan Y, Cifelli S, Johnson J, Chen M, Shiao LL, Zhou H, Previs S, Lei Y, Johnstone R, Liaw A, Saigal A, Hu L, Ramos R, Visconti R, McElroy WT, Kreamer A, Wildey MJ, Peier A, Shin MK, Imbriglio J, Ren Z, Hoek M, Weinglass A, Ai X (2021) High-throughput screening to identify small molecules that selectively inhibit APOL1 protein level in podocytes. SLAS Discov 26:1225–1237. https://doi.org/10.1177/24725552211026245
Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA, Friedman DJ, Bramham K, Campbell K, Knebelmann B, Barisoni L, Falk RJ, Gipson DS, Lipkowitz MS, Ojo A, Bunnage ME, Pollak MR, Altshuler D, Chertow GM, VX19-147-101 Study Group (2023) Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants. N Engl J Med 388:969–979. https://doi.org/10.1056/NEJMoa2202396
Wang Y, Nguyen HP, Xue P, Xie Y, Yi D, Lin F, Dinh J, Viscarra JA, Ibe NU, Duncan RE, Sul HS (2024) ApoL6 associates with lipid droplets and disrupts perilipin1-HSL interaction to inhibit lipolysis. Nat Commun 15:186. https://doi.org/10.1038/s41467-023-44559-3
Kislev N, Mor-Yossef Moldovan L, Barak R, Egozi M, Benayahu D (2022) MYH10 governs adipocyte function and adipogenesis through its interaction with GLUT4. Int J Mol Sci 23:2367. https://doi.org/10.3390/ijms23042367
Han L, Huang D, Wu S, Liu S, Wang C, Sheng Y, Lu X, Broxmeyer HE, Wan J, Yang L (2023) Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism. Nat Cell Biol 25:1033–1046. https://doi.org/10.1038/s41556-023-01162-4
Sheffield DA, Gurung R, Mitchell CA (2016) Role of phosphoinositides in membrane traffic. In: Bradshaw RA, Stahl PD (eds) Encyclopedia of cell biology. Academic Press, pp 503–519. https://doi.org/10.1016/B978-0-12-394447-4.20051-5
Fang R, Jiang Q, Jia X, Jiang Z (2023) ARMH3-mediated recruitment of PI4KB directs Golgi-to-endosome trafficking and activation of the antiviral effector STING. Immunity 56:500-515.e6. https://doi.org/10.1016/j.immuni.2023.02.004
Hirai Y, Nelson CM, Yamazaki K, Takebe K, Przybylo J, Madden B, Radisky DC (2007) Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesis. J Cell Sci 120:2032–2043. https://doi.org/10.1242/jcs.006247
Hagiwara-Chatani N, Shirai K, Kido T, Horigome T, Yasue A, Adachi N, Hirai Y (2017) Membrane translocation of t-SNARE protein syntaxin-4 abrogates ground-state pluripotency in mouse embryonic stem cells. Sci Rep 7:39868. https://doi.org/10.1038/srep39868
de Graaf P, Klapisz EE, Schulz TK, Cremers AF, Verkleij AJ, van Bergen en Henegouwen PM (2002) Nuclear localization of phosphatidylinositol 4-kinase beta. J Cell Sci 115:1769–1775. https://doi.org/10.1242/jcs.115.8.1769
Strahl T, Hama H, DeWald DB, Thorner J (2005) Yeast phosphatidylinositol 4-kinase, Pik1, has essential roles at the Golgi and in the nucleus. J Cell Biol 171:967–979. https://doi.org/10.1083/jcb.200504104
Szivak I, Lamb N, Heilmeyer LM (2006) Subcellular localization and structural function of endogenous phosphorylated phosphatidylinositol 4-kinase (PI4K92). J Biol Chem 281:16740–16749. https://doi.org/10.1074/jbc.M511645200
Fáberová V, Kalasová I, Krausová A, Hozák P (2020) Super-resolution localisation of nuclear PI(4)P and identification of its interacting proteome. Cells 9:1191. https://doi.org/10.3390/cells9051191
Simons C, Benkert J, Deuter N, Poetschke C, Pongs O, Schneider T, Duda J, Liss B (2019) NCS-1 deficiency affects mRNA levels of genes involved in regulation of ATP synthesis and mitochondrial stress in highly vulnerable substantia nigra dopaminergic neurons. Front Mol Neurosci 12:252. https://doi.org/10.3389/fnmol.2019.00252
Strahl T, Grafelmann B, Dannenberg J, Thorner J, Pongs O (2003) Conservation of regulatory function in calcium-binding proteins: human frequenin (neuronal calcium sensor-1) associates productively with yeast phosphatidylinositol 4-kinase isoform, Pik1. J Biol Chem 278:49589–49599. https://doi.org/10.1074/jbc.M309017200
Burri L, Lithgow T (2004) A complete set of SNAREs in yeast. Traffic 5:45–52. https://doi.org/10.1046/j.1600-0854.2003.00151.x
Funding
The work in author’s laboratory was supported by the European Research Council (ERC) grant 669007-APOLs.
Author information
Authors and Affiliations
Contributions
Not applicable.
Corresponding author
Ethics declarations
Conflict of interest
The author has no relevant financial or non-financial interests to disclose.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pays, E. The Janus-faced functions of Apolipoproteins L in membrane dynamics. Cell. Mol. Life Sci. 81, 134 (2024). https://doi.org/10.1007/s00018-024-05180-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-024-05180-9